Member Info for Bluebelly

Swervington.
I have no more ISA cash, but if sub £1.30 occurred, I would plough in some cash in my normal share dealing account (which is not normally used due to Tax self assessment requirements). Good luck to you.

BB

Could be the start of a good run - The technicals are swinging to an improved positive position also. That doesn't mean we couldn't have a double bottom. We are mere PI's, hang on to the coat tails of the big buyers that will move this when they are ready.
GLA

BB

Not sure how many you can buy and at what price (no cash), but it would appear the MM's want your shares.

BB

The MM's will follow a pattern to lure punters in and then suddenly change the format. All the punters trading daily will then miss the big jump and pay a premium or not return. That's my view and why I am holding, long & strong.

BB

Tils could still go against the flow.

BB

Lets hope the NASDAQ pushes the UK SP through £1.65 and becomes support.
Covid news today should raise some interest on the other side of the pond.

BB

Sell in the morning - buy back before close - seems to be the MO.

BB

A bit of a damp squib. Peaked higher yesterday than current sell price. Insiders and traders making the money at the moment.

BB

Lets say initially valued at £1 for ease. Tils shareholders get 1:1 so valued at £191m.
The IPO issues 209m shares at £1 making it 400m shares in issue.
Acustem mcap floats around £400m mark, with £200m in cash.
Tils holders from the demerger only have <50% of Acustem company due to IPO.
They still have Tils holding.

BB

13 trading days until Q4.

BB

Missed the boat, as I did or worse?

BB

By the end of Sept the top of the channel is @ 167p
Top of the old channel is around 350p end of Sept.
150 by close Friday could set us up for next week.

GLA

BB

https://uk.tradingview.com/chart/TILS/IIz8FLUH-Support-becomesresistance/

BB

'Industry metrics suggest that the current market valuation of TILS does not
fully reflect its underlying therapeutic pipeline and attributes no value to
StemPrintER, even at a discount to the takeover multiple paid by EXAS. We
suggest a target valuation of up to £700mln for its therapeutic programmes on
executing milestones over the next 12-18 months, with StemPrintER providing
pure upside to the current market valuation.'
This was written when our mcap was at £364m, now £272m with cash in the bank - 33% upsite to return to the above statement!
Undervalued at £364m for current pipeline and no value for StemprintER (£700m)

I will be holding.

BB

Funds & II - They will invest when we list on the FTSE Main listing and the broker releases a broker note with forecasts stating the drug pipeline and a foreward looking valuation for each drug should they complete successful phase 3 trials.

BB

Some entity had to sell 200k shares around £1.50 to raise the cash to buy 600k warrants at 50p.
They could be exercising the warrants to make sure they are in for the Special Divi announcement!!

BB

NM

BB

They can buy at 147.5p - So can we ish.
The only perk is, they can buy them at any time up to four years from now. When the SP is probably above £10. Or are these being issued now due to what's going on behind the scenes. I think I'll just hold for the time being and avoid the noise.

GLA

BB

Or the price will gap up and open very much higher.

Then you can dip in & out having had the forewarning RNS stating - We are minted!!!!!

BB

I would expect the main listing to occur before any demerger announcement. This allows Fund Managers to buy into Tils as some serious funds do not touch AIM shares.
A circular could be sent out early September having entered the main market, with a cut -off date shortly after, stating Demerger will complete xx days from this RNS date (Oct/Nov). Don't get caught out trading for pennies/share when £'s/share could be inbound.

BB